AfricSanté, Burkina Faso Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2018
NCT03533712
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AFRICSante | AfricSanté, Burkina Faso

Active Ingredients

Drugs in Phase 4 Trials (2)

folic acid (1 trial)

iron (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 4)

Infant Nutrition Disorders (Phase 4)

Malnutrition (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2